BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Apolipoprotein A Ii

The second most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. It has a high lipid affinity and is known to displace APOLIPOPROTEIN A-I from HDL particles and generates a stable HDL complex. ApoA-II can modulate the activation of LECITHIN CHOLESTEROL ACYLTRANSFERASE in the presence of APOLIPOPROTEIN A-I, thus affecting HDL metabolism.

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 47.9

Research Domains

Apolipoprotein A Ii has been studied across 15 research domains including 🔥 Metabolic, ❤️ Cardiovascular, 🫁 Liver & Detox, 🧠 Neuroprotection, 🧠 Focus & Attention. The primary research focus is 🔥 Metabolic with 28% of studies addressing this area.

Loading evidence profile...

This evidence profile for Apolipoprotein A Ii is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.